News and Press Releases
Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3
23 January 2025 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 23, 2025
Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom
PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
VE303 was well tolerated and decreased the odds of rCDI through multiple mechanisms Analyses identified predictors of VE303 colonization and protection from CDI recurrence Topline data for the ongoing Phase...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: January 23, 2025
Spektus Pharma and Recipharm Announce Strategic Partnership to Develop and Supply CNS Medicines Using Flexitab™ Oral Drug Delivery Platform
22 January 2025 -- Montreal, Canada -- Spektus Pharma, an innovator in value added medicine development, and Recipharm, a leading global contract development and manufacturing organization, have entered into a...
Category: Drug Discovery, Other, Pharmaceutical
Posted: January 22, 2025
ACG to Showcase Sustainable Packaging Innovations at Pharmapack Paris 2025
Welcomes Jochen Scheil as Head of Global Sales for ACG Packaging Materials 21 January 2025 -- Paris, France -- ACG, the world’s leading supplier of integrated solutions for the pharmaceutical...
Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 21, 2025
Advarra Introduces Comprehensive Solution to Accelerate Study Startup and Improve Collaboration on Trials
Proven technology powers end-to-end solution designed to streamline site activation workflows, improve engagement, and optimize visibility among trial stakeholders 21 January 2025 -- Maryland, US -- Advarra, the market leader...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: January 21, 2025
Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 21, 2025
11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ
European Commission approves LAZCLUZE®▼ (lazertinib) in combination with RYBREVANT®▼ (amivantamab) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer
Latest topline data from the Phase 3 MARIPOSA study shows amivantamab plus lazertinib is the first regimen to demonstrate superior overall survival benefit compared to the current standard of care...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: January 21, 2025
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Opella reaches study milestone for Cialis
21 January 2025 -- Paris, France -- Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual...
Category: Clinical Trials, Other, Pharmaceutical
Posted: January 21, 2025
Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate
£500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis Programme delivered by CF AMR Syndicate offers cross-sector collaboration and...
Category:
Posted: January 21, 2025
11 The Square University Of Glasgow University Avenue Glasgow G12 8QQ
First patients treated with HEMGENIX® (etranacogene dezaparvovec) gene therapy for haemophilia B in Denmark
21 January 2025 – Copenhagen, Denmark – CSL Behring Denmark today announced that the first Danish patients with haemophilia B were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec). HEMGENIX®...
Category:
Posted: January 21, 2025
Avery Dennison and partners to showcase RFID-enabled digital ID solution for pre-filled syringe traceability at Pharmapack 2025
16 January 2025 – Mentor, OH, US – Avery Dennison has announced its plans for Pharmapack 2025, which includes showcasing a groundbreaking RFID (radio frequency identification) pre-filled syringe (PFS) authentication...
Category: Drug Delivery, Manufacturing and Packing
Posted: January 20, 2025
Cymphony is urgently advocating for improved communication to meet the rapidly growing demand from Gen Z and Millennial patients
Now more than ever, patients are seeking timely and efficient ways to communicate with their healthcare providers 20 January 2025 -- Crewe, UK -- Given the recent uptick in private...
Category: Logistics, Other, Pharmaceutical
Posted: January 20, 2025
Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain’s fastest-growing private technology companies
Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research services...
Category: Biotechnology
Posted: January 20, 2025
Metrion Biosciences Building, B501 Babraham, Research Campus, Cambridge, CB22 3AT, UK
BD Highlights the Latest Innovations in Drug Delivery at Pharmapack 2025
20 January 2025 -- New Jersey, US -- BD (Becton, Dickinson and Company), a leading global medical technology company, will showcase a wide range of cutting-edge drug delivery innovations at...
Category: Biotechnology, Drug Delivery, Logistics, Other, Pharmaceutical
Posted: January 20, 2025
Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of...
Category: Drug Discovery
Posted: January 17, 2025
Owlstone Ltd, 127 Cambridge Science Park, Milton Road, Cambridge, CB4 0GD, UK
